The relationship between hyperpolypharmacy and one-year outcomes in patients with critical limb ischemia undergoing below-knee endovascular therapy
Yazarlar (10)
Mehmet Altunova
University Of Health Sciences, Türkiye
University Of Health Sciences, Türkiye
Recep Gülmez University Of Health Sciences, Antigua ve Barbuda
Dr. Öğr. Üyesi Muammer KARAKAYALI Kafkas Üniversitesi, Türkiye
İsmail Gürbak
University Of Health Sciences, Antigua ve Barbuda
University Of Health Sciences, Antigua ve Barbuda
Ömer Taşbulak
University Of Health Sciences, Antigua ve Barbuda
University Of Health Sciences, Antigua ve Barbuda
Gökhan Demirci
University Of Health Sciences, Antigua ve Barbuda
University Of Health Sciences, Antigua ve Barbuda
Arda Güler University Of Health Sciences, Antigua ve Barbuda
Ali Evsen
Dicle University, Faculty Of Medicine, Türkiye
Dicle University, Faculty Of Medicine, Türkiye
Ümit Bulut Kırşehir Ahi Evran Üniversitesi, Türkiye
Mehmet Ertürk Sağlık Bilimleri Üniversitesi, Türkiye
| Makale Türü | Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale) | ||
| Dergi Adı | Vascular | ||
| Dergi ISSN | 1708-5381 Wos Dergi Scopus Dergi | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | Türkçe | Basım Tarihi | 04-2024 |
| Cilt / Sayı / Sayfa | 32 / 2 / 320–329 | DOI | 10.1177/17085381231193496 |
| Makale Linki | http://dx.doi.org/10.1177/17085381231193496 | ||
| Özet |
| BackgroundCritical limb ischemia (CLI) patients take too many medications because they are elderly and frail patients with multiple comorbidities. Polypharmacy is associated with frailty, although its prognostic significance in CLI patients is unknown. In this study, we aimed to determine the prevalence of hyperpolypharmacy among adults with CLI and its effect on 1-year amputation and mortality.MethodsA total of 200 patients with CLI who underwent endovascular therapy (EVT) for below-knee (CTC) lesions were included in this study. Hyperpolypharmacy was defined as using ≥10 drugs. Patients were divided into two groups according to the presence of hyperpolypharmacyResultsWe detected hyperpolypharmacy in 66 patients. The incidence of 1-year amputation [24 (36.4) versus 12 (9), p<.001] and mortality [28 (42.4) versus 12 (9), p<.001] were higher in patients with hyperpolypharmacy. Univariate and … |
| Anahtar Kelimeler |
| 1-year mortality | critical limb ischemia | endovascular therapy | Hyperpolypharmacy | major amputation |
BM Sürdürülebilir Kalkınma Amaçları
| Atıf Sayıları | |
| Google Scholar | 4 |
| Web of Science | 3 |
| Scopus | 3 |